A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 1
- Study design
- RANDOMIZED · PARALLEL · OTHER · TRIPLE
- Evidence population
- Human clinical study registration
- Participants
- 48
- Population
- ALL · 65 Years
- Duration
- 2018-12-06 to 2020-12-01
- Intervention
- Nicotinamide Riboside and Pterostilbene; Placebo
- Comparator
- Placebo
- Outcomes measured
- Complications — 90 days; Grip Strength Scores — 90 days; Inhalation Volume Measurements — 90 days; 6 Minute Timed Walk Test Scores — 90 days; Timed Get Up and Go Test Scores — 90 days; Measurement of Muscle/ Fat Ratio — 90 days; Incidence of Adverse Events — 90 days; Incidence of Pain and Daily Pain Medication Dosage — 90 days; Analysis of Quality of Life Scores — 90 days; Late Life Function and Disability Instrument Scores analysis as a measure of subject independence, function, and disabi…; Analysis of scores on Mini Mental Status Exam as a measure of cognitive function and dementia — 90 days; Analysis of subject nutrition through Mini Nutritional Assessment Scores — 90 days; Analysis of Subject independence using Barthel Index scores — 90 days; Analysis of patient comorbidities as a measure of adverse events in evaluating Basis tolerability — 90 days; Analysis of inflammatory cell activity — 90 days; Analysis of Mitochondrial Function — 90 days
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sirtuins · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.